Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by Kaiseron Sep 15, 2021 11:10am
77 Views
Post# 33861644

RE:RE:RE:RE:RE:RE:Confused

RE:RE:RE:RE:RE:RE:Confused

Lolololololololololol well guess you're going to chnage your name
to nomoremoneymoe. Sona was around $1.50 when this was posted April 26.  Poor moe.

Moemoney42 wrote:

stockmonster6 wrote: Only time will tell, but I'd put my money on THRM before SONA, who has messed up royally in the past and seems to be putting the cart before the horse again but applying to HC without presenting any saliva test results in the lab.  Seems backwards to me.

Few more months, and let's hope either/or gets a successful test to market.

I'd also like to add.. do you think all THRM's missed self emposed deadlines to the tune of probably at least 6 now wouldn't be considered "messed up"..?? Or how adding new hurdles with every PR that should have been addressed right from the start.. like requiring an ethics approval before testing... 3 months after they said in early Dec. they plan to have testing completed by mid Jan. 2021.. OMG!! 


<< Previous
Bullboard Posts
Next >>